Cidara Therapeutics CDTX
$ 18.74
23.94%
Quarterly report 2024-Q3
added 11-07-2024
Cidara Therapeutics Cash Flow 2011-2024 | CDTX
Annual Cash Flow Cidara Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-22.4 M | -28.5 M | -25.2 M | -54.4 M | -28.5 M | -56.7 M | -49.9 M | -39.8 M | - | - | - | - | - |
Depreciation & Amortization |
112 K | 143 K | 189 K | 286 K | 328 K | 523 K | 667 K | 732 K | 461 K | 179 K | - | - | - |
Accounts Payables |
3.77 M | 1.45 M | 1.3 M | 4.57 M | 1.89 M | 2.85 M | 2.59 M | 2.91 M | 3.1 M | - | - | - | - |
Accounts Receivables |
16.2 M | 5.83 M | 5.36 M | 11.2 M | - | - | 321 K | - | - | - | - | - | - |
Total Inventories |
6.1 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Cidara Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -6.64 M | - | - | - | -10.9 M | - | -7.47 M | -35.4 M | -23.6 M | - | -10.3 M | 1.65 M | -1.79 M | - | -43.3 M | -29.2 M | -15.1 M | - | -13.3 M | -30 M | -17.1 M | - | -43 M | - | - | - | -40.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 36 K | - | - | - | 32 K | - | 114 K | 77 K | 39 K | - | 152 K | 107 K | 57 K | - | 219 K | 143 K | 71 K | - | 251 K | 170 K | 86 K | - | 412 K | 275 K | 139 K | - | 528 K | 384 K | 198 K | - | 547 K | 369 K | 179 K | - | 289 K | 189 K | 91 K | - | 89 K | 19 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
2.97 M | 2.29 M | 5.06 M | 3.77 M | 3.66 M | 1.9 M | 3.98 M | 1.45 M | 4.24 M | 3.09 M | 2.86 M | 1.3 M | 3.24 M | 2.59 M | 3.22 M | 4.57 M | 4.57 M | 4.57 M | 4.57 M | 1.89 M | 1.89 M | 1.89 M | 1.89 M | 2.85 M | 2.85 M | 2.85 M | 2.85 M | 2.59 M | 2.59 M | 2.59 M | 2.59 M | 2.91 M | 2.91 M | 2.91 M | 2.91 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 1.18 M | 1.18 M | 1.18 M | 1.18 M | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
1.7 M | 2.35 M | 7.28 M | 14.1 M | 2.86 M | 5.48 M | 25.8 M | 5.83 M | 5.04 M | 4.83 M | 8.78 M | 5.36 M | 3.87 M | 3.16 M | 11 K | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 10 K | - | - | - | - | - | 41 K | 288 K | 321 K | 321 K | 321 K | 321 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | 7.27 M | 6.1 M | 2.47 M | 1.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency